AstroNova, Inc. Files 10-Q for Q3 2024
Ticker: ALOT · Form: 10-Q · Filed: Dec 12, 2024 · CIK: 8146
| Field | Detail |
|---|---|
| Company | Astronova, INC. (ALOT) |
| Form Type | 10-Q |
| Filed Date | Dec 12, 2024 |
| Risk Level | low |
| Pages | 15 |
| Reading Time | 18 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, quarterly-report
TL;DR
AstroNova 10-Q filed. Q3 results out. Check financials.
AI Summary
AstroNova, Inc. filed its 10-Q for the period ending November 2, 2024, reporting on its financial performance. The company's fiscal year ends on January 31st, with the current report covering the third quarter. Key financial data and operational details are provided within this filing.
Why It Matters
This filing provides investors with a quarterly update on AstroNova's financial health and operational activities, crucial for investment decisions.
Risk Assessment
Risk Level: low — This is a standard quarterly financial filing with no immediate red flags.
Key Players & Entities
- AstroNova, Inc. (company) — Filer of the 10-Q
- November 2, 2024 (date) — End of reporting period
- January 31 (date) — Fiscal year end
- 0000950170-24-135721 (other) — Accession number for the filing
FAQ
What is the reporting period for this 10-Q filing?
The 10-Q filing is for the period ending November 2, 2024.
When does AstroNova, Inc. typically end its fiscal year?
AstroNova, Inc.'s fiscal year ends on January 31st.
What is the company's Central Index Key (CIK)?
The company's Central Index Key (CIK) is 0000008146.
What is the company's business address?
The business address is 600 E GREENWICH AVENUE, WEST WARWICK, RI 02893.
What was the former name of AstroNova, Inc.?
The company was formerly known as ASTRO MED INC /NEW/.
Filing Stats: 4,426 words · 18 min read · ~15 pages · Grade level 16.8 · Accepted 2024-12-12 15:00:24
Filing Documents
- alot-20241102.htm (10-Q) — 2486KB
- alot-ex31_1.htm (EX-31.1) — 15KB
- alot-ex31_2.htm (EX-31.2) — 15KB
- alot-ex32_1.htm (EX-32.1) — 10KB
- alot-ex32_2.htm (EX-32.2) — 9KB
- 0000950170-24-135721.txt ( ) — 11541KB
- alot-20241102.xsd (EX-101.SCH) — 1465KB
- alot-20241102_htm.xml (XML) — 2434KB
Financial Statements
Financial Statements Unaudited Condensed Consolidated Balance Sheets – November 2, 2024 and January 31, 2024 1 Unaudited Condensed Consolidated Statements of Income – Three and Nine Months Ended November 2, 2024 and October 28, 2023 2 Unaudited Condensed Consolidated Statements of Comprehensive Income – Three and Nine Months Ended November 2, 2024 and October 28, 2023 3 Unaudited Condensed Consolidated Statements of Changes in Shareholders' Equity – Three and Nine Months Ended November 2, 2024 and October 28, 2023 4 Unaudited Condensed Consolidated Statements of Cash Flows – Nine Months Ended November 2, 2024 and October 28, 2023 5 Notes to the Condensed Consolidated Financial Statements (unaudited) 6 Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 24 Item 3.
Quantitative and Qualitative Disclosures about Market Risk
Quantitative and Qualitative Disclosures about Market Risk 32 Item 4.
Controls and Procedures
Controls and Procedures 32 Part II. Other Information 33 Item 1.
Legal Proceedings
Legal Proceedings 33 Item 1A.
Risk Factors
Risk Factors 33 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 34 Item 6. Exhibits 35
Signatures
Signatures 36 Pa rt I. FINANCIAL INFORMATION It em 1. Financial Statements ASTRONOVA, INC. CONDENSED CONSOL IDATED BALANCE SHEETS (In Thousands, Except Share Data) November 2, 2024 January 31, 2024 (Unaudited) ASSETS CURRENT ASSETS Cash and Cash Equivalents $ 4,432 $ 4,527 Accounts Receivable, net 25,156 23,056 Inventories, net 48,560 46,371 Prepaid Expenses and Other Current Assets 5,239 2,720 Total Current Assets 83,387 76,674 Property, Plant and Equipment, net 18,366 14,185 Identifiable Intangibles, net 24,514 18,836 Goodwill 25,337 14,633 Deferred Tax Assets, net 11,187 6,882 Right of Use Asset 1,946 603 Other Assets 1,725 1,438 TOTAL ASSETS $ 166,462 $ 133,251 LIABILITIES AND SHAREHOLDERS' EQUITY CURRENT LIABILITIES Accounts Payable $ 7,933 $ 8,068 Accrued Compensation 3,304 2,923 Other Accrued Expenses 3,676 2,706 Revolving Line of Credit 20,215 8,900 Current Portion of Long-Term Debt 6,328 2,842 Short-Term Debt 1,334 — Current Liability—Royalty Obligation 1,450 1,700 Current Liability—Excess Royalty Payment Due 864 935 Income Taxes Payable — 349 Deferred Revenue 378 1,338 Total Current Liabilities 45,482 29,761 NON-CURRENT LIABILITIES Long-Term Debt, net of current portion 21,072 10,050 Royalty Obligation, net of current portion 1,511 2,093 Lease Liabilities, net of current portion 1,681 415 Grant Deferred Revenue 1,412 — Income Taxes Payable 551 551 Deferred Tax Liabilities 2,580 99 TOTAL LIABILITIES 74,289 42,969 SHAREHOLDERS' EQUITY Preferred Stock, $ 10 Par Value, Authorized 100,000 shares, None Issued — — Common Stock, $ 0.05 Par Value, Authorized 13,000,000 shares; Issued 10,921,780 and 10,812,137 shares at November 2, 2024 and January 31, 2024, respectively 546 541 Additional Paid-in Capital 63,949 62,684 Retained